Edition:
United States

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

13.07EUR
23 Feb 2018
Change (% chg)

€-0.06 (-0.46%)
Prev Close
€13.13
Open
€13.13
Day's High
€13.17
Day's Low
€12.98
Volume
89,742
Avg. Vol
227,979
52-wk High
€13.74
52-wk Low
€10.02

Chart for

About

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in... (more)

Overall

Beta: 1.65
Market Cap(Mil.): €943.31
Shares Outstanding(Mil.): 71.84
Dividend: 0.10
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.98 16.31
EPS (TTM): -- -- --
ROI: -- 14.12 35.74
ROE: -- 15.72 17.71

BRIEF-Fagron FY Rebitda Increased 5.7% To 95.7 Million Euros

* REG-FAGRON TURNOVER INCREASED BY 3.6% TO € 436.9 MILLION AND NET PROFIT INCREASED TO € 47.0 MILLION

Feb 07 2018

BRIEF-Cannimed Therapeutics Announces Cannabis Distribution Agreement With Fagron NV

* CANNIMED THERAPEUTICS INC. ANNOUNCES STRATEGIC INTERNATIONAL CANNABIS DISTRIBUTION AGREEMENT WITH FAGRON NV

Jan 10 2018

BRIEF-Fagron appoints ‍Rafael Padilla to succeed Hans Stols as CEO

* ‍MR. STOLS WILL RESIGN FROM ALL HIS FUNCTIONS AND MANDATES WITH IMMEDIATE EFFECT​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Nov 27 2017

BRIEF-Fagron Q3 turnover ‍​up at 103.6 million euros

* Q3 TURNOVER EUR ‍​103.6 MILLION VERSUS EUR 103.4 MILLION YEAR AGO

Oct 12 2017

BRIEF-Fagron acquires All Chemistry in Brazil

* FAGRON FURTHER EXECUTES BUY-AND-BUILD STRATEGY WITH ACQUISITION OF ALL CHEMISTRY IN BRAZIL Source text: http://bit.ly/2yJwvbB Further company coverage: (Gdynia Newsroom)

Oct 05 2017

Earnings vs. Estimates